Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD
About this title
Read the official source — NCT02168127This study evaluated the safety and effectiveness of PRC-063 for people with ADHD.
Understand this study
What did researchers investigate?
This study evaluated the safety and effectiveness of PRC-063 for people with ADHD.
Who was this study for?
This study was for people with ADHD. Listed age limits: from 12 years. Other eligibility criteria applied.
- Listed locations
- Los Angeles and 34 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 360
- Sponsor
- Rhodes Pharmaceuticals, L.P.
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Canada
- Age range
- Over 12 Years
- Official registry ID
- NCT02168127
- Official title
Show the full official title
A Six-month, Open-label, Multi-center Study of the Safety and Efficacy of PRC-063 in Adults and Adolescents With ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Los Angeles, United States · National City, United States · Newport Beach, United States
30 more locations
- Orange, United States
- Bradenton, United States
- Gainesville, United States
- Jacksonville, United States
- Maitlin, United States
- Orlando, United States
- Boise, United States
- Las Vegas, United States
- New York, United States
- Raleigh, United States
- Cincinnati, United States
- Oklahoma City, United States
- Portland, United States
- Salem, United States
- Memphis, United States
- Austin, United States
- Dallas, United States
- Houston, United States
- Lubbock, United States
- Clinton, United States
- Salt Lake City, United States
- Woodstock, United States
- Herndon, United States
- Friday Harbor, United States
- Kirkland, United States
- Vancouver, Canada
- Niagara Falls, Canada
- Ottawa, Canada
- Whitby, Canada
- Sherbrooke, Canada
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the safety and effectiveness of PRC-063 for people with ADHD.
Who is behind this study?
The study sponsor is Rhodes Pharmaceuticals, L.P.
Did this study involve medication?
Yes. The study involved medication, including Drug: PRC-063 and PRC-063.
Who was this study for?
This study was for people with ADHD. Listed age limits: from 12 years. Other eligibility criteria applied.
